ISLAMABAD, September 7 (Online): A recent study has revealed that an antibody-based blockade might effectively treat cytokine release syndrome (CRS) and alleviate severe cases of COVID-19. The global race to
An antibody-based arthritis drug could treat severe COVID19.
